Publication:
Myocarditis Related to COVID-19 and SARS-CoV-2 Vaccination.

Simple item page
dc.contributor.authorMolina-Ramos, Ana I
dc.contributor.authorGomez-Moyano, Elisabeth
dc.contributor.authorRodriguez-Capitan, Jorge
dc.contributor.authorAngullo-Gomez, Maria
dc.contributor.authorGallardo-Jimenez, Patricia
dc.contributor.authorPerez-de-Pedro, Ivan
dc.contributor.authorValiente-de-Santis, Lucia
dc.contributor.authorPerez-Villardon, Beatriz
dc.contributor.authorPiñero-Uribe, Isabel
dc.contributor.authorMora-Robles, Javier
dc.contributor.authorBecerra-Muñoz, Victor Manuel
dc.contributor.authorJimenez-Navarro, Manuel
dc.contributor.funderCIBERCV “Enfermedades Cardiovasculares”
dc.contributor.funder“Instituto de Salud Carlos III”
dc.contributor.funderSpanish Ministry of Health
dc.contributor.funderFondo Europeo de Desarrollo Regional (FEDER)
dc.contributor.funderInstituto de Salud Carlos III
dc.contributor.funderERDF/ESF
dc.contributor.funderConsejería de Salud y Familias—Junta de Andalucía
dc.date.accessioned2023-05-03T14:11:06Z
dc.date.available2023-05-03T14:11:06Z
dc.date.issued2022-11-26
dc.description.abstractThe coronavirus disease of 2019 (COVID-19) has been a cause of significant morbidity and mortality worldwide. Among the short- and long-term consequences of COVID-19, myocarditis is a disease to be taken into consideration. Myocarditis, in general, is related to a poor prognosis. However, the epidemiology and prognosis of myocarditis related to COVID-19 are currently unknown. While vaccination against COVID-19 is of great benefit at a public health level, the risk of myocarditis should be considered in the context of the global benefits of vaccination. In this narrative review, we will summarize the etiopathogenic bases, the epidemiology, the clinical manifestations, the course, diagnosis, prognosis, and the treatment of myocarditis related to SARS-CoV-2, as well as myocarditis secondary to mRNA vaccines.
dc.description.versionSi
dc.identifier.citationMolina-Ramos AI, Gómez-Moyano E, Rodríguez-Capitán J, Angullo-Gómez M, Gallardo-Jiménez P, Pérez de Pedro I, et al. Myocarditis Related to COVID-19 and SARS-CoV-2 Vaccination. J Clin Med. 2022 Nov 26;11(23):6999
dc.identifier.doi10.3390/jcm11236999
dc.identifier.issn2077-0383
dc.identifier.pmcPMC9738968
dc.identifier.pmid36498573
dc.identifier.pubmedURLhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9738968/pdf
dc.identifier.unpaywallURLhttps://www.mdpi.com/2077-0383/11/23/6999/pdf?version=1670205463
dc.identifier.urihttp://hdl.handle.net/10668/21365
dc.issue.number23
dc.journal.titleJournal of clinical medicine
dc.journal.titleabbreviationJ Clin Med
dc.language.isoen
dc.organizationHospital Universitario Virgen de la Victoria
dc.organizationHospital Universitario Regional de Málaga
dc.organizationCentro Andaluz de Nanomedicina y Biotecnología-BIONAND
dc.organizationInstituto de Investigación Biomédica de Málaga-IBIMA
dc.page.number13
dc.provenanceRealizada la curación de contenido 22/04/2025
dc.publisherMDPI
dc.pubmedtypeJournal Article
dc.pubmedtypeReview
dc.relation.projectIDCB16/11/ 00360
dc.relation.projectIDCM21/00027
dc.relation.projectIDRH-0095-2020
dc.relation.publisherversionhttps://www.mdpi.com/resolver?pii=jcm11236999
dc.rightsAttribution 4.0 International
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subjectCOVID-19
dc.subjectmRNA vaccines
dc.subjectMyocarditis
dc.subject.decsMiocarditis
dc.subject.decsEpidemiología
dc.subject.decsSARS-CoV-2
dc.subject.decsCoronavirus
dc.subject.decsSalud pública
dc.subject.decsVacunas de ARNm
dc.subject.meshSARS-CoV-2
dc.subject.meshPrognosis
dc.subject.meshVaccination
dc.subject.meshHealth Status
dc.titleMyocarditis Related to COVID-19 and SARS-CoV-2 Vaccination.
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number11
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
PMC9738968.pdf
Size:
7.6 MB
Format:
Adobe Portable Document Format
Download

Collections

SAS - Hospital Universitario Virgen de la Victoria
Instituto de Investigación Biomédica de Málaga - Plataforma Bionand (IBIMA)
SAS - Hospital Regional Universitario de Málaga

© 2023 – Repositorio Institucional de Salud de Andalucía - Fundación Pública Andaluza Progreso y Salud - Consejería de Salud y Consumo de la Junta de Andalucía